Diagnostic value of cerebrospinal fluid antibodies in herpes simplex virus encephalitis.

Por Koskiniemi, M L, Vaheri, A
Publicado em 1982

Cerebrospinal fluid plasminogen activator inhibitor-1 in patients with neurological disease.

Por Akenami, F O, Koskiniemi, M, Färkkilä, M, Vaheri, A
Publicado em 1997

Herpes encephalitis is a disease of middle aged and elderly people: polymerase chain reaction for detection of herpes simplex virus in the CSF of 516 patients with encephalitis. Th...

Por Koskiniemi, M, Piiparinen, H, Mannonen, L, Rantalaiho, T, Vaheri, A
Publicado em 1996

Piracetam relieves symptoms in progressive myoclonus epilepsy: a multicentre, randomised, double blind, crossover study comparing the efficacy and safety of three dosages of oral p...

Por Koskiniemi, M., Van Vleymen, B., Hakamies, L., Lamusuo, S., Taalas, J.
Publicado em 1998

Chlamydia trachomatis detected in human placenta.

Por Gencay, M, Puolakkainen, M, Wahlström, T, Ammälä, P, Mannonen, L, Vaheri, A, Koskiniemi, M L
Publicado em 1997

Cerebrospinal fluid activity of tissue plasminogen activator in patients with neurological diseases.

Por Akenami, F O, Sirén, V, Koskiniemi, M, Siimes, M A, Teräväinen, H, Vaheri, A
Publicado em 1996

Antibodies to varicella zoster virus in the cerebrospinal fluid of neonates with seizures

Por Mustonen, K., Mustakangas, P., Smeds, M., Mannonen, L., Uotila, L., Vaheri, A., Koskiniemi, M.
Publicado em 1998

Localization of a gene for progressive myoclonus epilepsy to chromosome 21q22.

Por Lehesjoki, A E, Koskiniemi, M, Sistonen, P, Miao, J, Hästbacka, J, Norio, R, de la Chapelle, A
Publicado em 1991